Tobi/Tobi Podhaler

Drug Overview
Product Profiles
Tobi/Tobi Podhaler : Cystic fibrosis

Figure 1: Tobi/Tobi Podhaler for cystic fibrosis – SWOT analysis
Figure 2: The authors drug assessment summary of Tobi/Tobi Podhaler for cystic fibrosis
Figure 3: The authors drug assessment summary of Tobi/Tobi Podhaler for cystic fibrosis
Figure 4: Tobi/Tobi Podhaler sales for cystic fibrosis across the US and five major EU markets, by country, 2016–25

Table 1: Tobi/Tobi Podhaler drug profile
Table 2: Tobi/Tobi Podhaler Phase III data in cystic fibrosis
Table 3: Tobi/Tobi Podhaler sales for cystic fibrosis across the US and five major EU markets, by country ($m), 2016–25